Detalhe da pesquisa
1.
Diagnosis and management of neuroendocrine prostate cancer.
Prostate
; 84(5): 426-440, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38173302
2.
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial.
Lancet Oncol
; 24(11): 1266-1276, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922930
3.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597472
4.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
; 128(2): 196-205, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556233
5.
Hypertension in Young Adults and Subsequent Cardiovascular Disease.
JAMA
; 321(13): 1310, 2019 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30938789
6.
Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval.
J Nucl Med
; 65(5): 735-739, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485274
7.
Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
J Nucl Med
; 65(2): 199-205, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212070
8.
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.
Urol Oncol
; 41(3): 145.e7-145.e15, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36435709
9.
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer.
Front Oncol
; 13: 1161089, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37091148
10.
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin.
Clin Genitourin Cancer
; 21(5): e394-e404, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37316414
11.
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 28(8): 1531-1539, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176163
12.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(6): 558-567, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36155169
13.
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer
; 20(2): 165-175, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078711
14.
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(5): e440-e452, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778337
15.
Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: a narrative review.
Transl Androl Urol
; 10(7): 3130-3143, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430416
16.
TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor.
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980590
17.
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Eur Urol Oncol
; 4(3): 464-472, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423945
18.
Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.
Am J Med
; 132(6): 722-732.e7, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659809
19.
20.
Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer.
Eur Urol
; 81(2): 219-221, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758912